The monsoon brings dampness, which can turn your home into a hidden source of mould, a real threat to your lungs. Pulmonary ...

Market Growth Driven by Rising Respiratory and Sleep Disorders, Aging Population, Advanced Device Technologies, and Expanding ...

Antibiotic demand for pneumonia and COPD in the top 20 countries showed high global consumption. Researchers conducted a ...

The FDA recently approved mepolizumab for treating adults with inadequately controlled COPD and an eosinophilic phenotype, ...

In smokers with COPD, LABA+LAMA is more effective than LABA+ICS in preventing exacerbations, regardless of blood eosinophil count.

Researchers discover an unusual accumulation of particles in people with the disease; the causes are still unclear.

Between 14 days and 1 day out from an acute exacerbation of COPD, a digital inhaler measured significant drops in inhalation ...

Regardless of chronic obstructive pulmonary disease status, finerenone mitigates clinical events and symptoms in patients with HFmrEF or HFpEF.

The deep cuts to Medicaid outlined in President Trump’s budget reconciliation bill would hurt Americans suffering from conditions like chronic obstructive pulmonary disease (COPD), Rep. Maxine ...

Long-term oxygen therapy (LTOT) is linked to reduced exacerbations and hospitalizations in COPD, ILD, and pulmonary hypertension.

Compared with tezepelumab, solrikitug demonstrated unique epitope binding and superior potency across several assays.